
S H Kelkar & Company Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
No
Order
No
Capex
No
0 of 5 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Company targets a 10-12% year-on-year revenue growth for the mid-term (3 to 5 years), with potential to exceed this based on current strong order wins.
- Growth is expected across all regions including Europe, India, Southeast Asia, and new markets like the US.
- Volume growth outpaces price increases; last quarter’s growth primarily driven by volume with minimal price impact (~1-2%).
- Market share expansion in India and growth in Flavours segment anticipated to contribute materially.
- New product introductions and new accounts (including wins from a global MNC) expected to add meaningful revenue from H2 FY25 onwards.
- Southeast Asia factory commissioning to boost regional growth.
- Lower capacity utilization (<50%) allows for operating leverage and volume growth without major capex in near term.
- E-commerce and startup segments in India identified as growth drivers.
- Overall, sustained double-digit growth in volume and sales targeted with a focus on market penetration and operational efficiency.
See what S H Kelkar & Company management said on margin guidance — free account, 30 seconds.
Fundraise plans
NoSee what S H Kelkar & Company management said on order book — free account, 30 seconds.
Capex plans
No- Current large capex: Indonesia factory, expected to be ready by next financial year.
- No large production capex expected in the coming year; focus on incremental capex.
- Incremental capex targeted at product development teams and infrastructure to support growth and diverse projects.
- Product development teams expected to double or triple in the next 3-4 years.
- European facilities (Italy and Netherlands) optimized for increased production without significant capex currently.
- Possible new manufacturing or development capex in Europe anticipated around 18 months from now (2025-26).
- No major inorganic acquisitions planned; focus on organic growth through subsidiaries in the US and Europe.
- Capital allocation policy involves distributing 30-40% of cash profit as dividends or share buybacks; incremental cash likely to be used for debt repayment.
Track S H Kelkar & Company — get its next earnings analysis in your feed
How does S H Kelkar & Company rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does S H Kelkar & Company rank in Chemicals & Petrochemicals?
Compare S H Kelkar & Company against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.
Continue your research
What S H Kelkar & Company's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…